Clostridium difficile (C. difficile) is the causative agent of antibiotic-associated diarrhoea and pseudomembranous colitis. It produces two major exotoxins (toxin A and toxin B), which are the prototypes of the family of large clostridial cytotoxins. Some strains of C. difficile also produce a binary ADP-ribosylating toxin (CDT) which modifies actin. The pathogenic role of CDT binary toxin in diseases induced by C. difficile is not clear, but about 10% of strains isolated from patients with colitis contain CDT binary toxin genes.
List Labs manufactures highly purified native Clostridium difficile toxins: toxin A (TcdA) and toxin B (TcdB), for research use; TcdA is available lyophilised in buffer, whereas TcdB is available in a liquid formulation. They are distributed in Australia and New Zealand by Sapphire Bioscience.
Phone: 02 9698 2022
Bioss In Vivo Biosimilar Antibodies
Bioss In Vivo Biosimilar Antibodies are research-grade copies of therapeutic antibodies that are...
LSBio virology research products
LSBio offers antibodies, proteins, ELISA kits, assay kits and chemical compounds used by...
Beckman Coulter Life Sciences IR820 and IR870 infrared dye antibody conjugates
The products provide research flow cytometry labs with a low-noise solution, including single...
